Eli Lilly and Company logo

Crystallization Process Development Engineer – Drug Substance SMDD

Eli Lilly and Company

Indianapolis, INOnsitePosted 1 day ago$130,500 - $211,200/year
Full TimeSenior LevelManufacturing & CMCPharmaceutical
Original posting ↗

Summary

Crystallization is where chemistry becomes medicine — the step that determines whether a promising molecule can be reliably purified, formulated, and manufactured at scale. We're looking for an outstanding crystallization engineer to join our Crystallization Science team and take ownership of that critical transformation across an exciting and diverse pipeline of small molecules, oligonucleotides, and synthetic peptides.

Job description

Shape How Tomorrow's Medicines Take Shape

Crystallization is where chemistry becomes medicine — the step that determines whether a promising molecule can be reliably purified, formulated, and manufactured at scale. We're looking for an outstanding crystallization engineer to join our Crystallization Science team and take ownership of that critical transformation across an exciting and diverse pipeline of small molecules, oligonucleotides, and synthetic peptides.

What You'll Do

  • Lead crystallization process design end-to-end — from first-principles science (nucleation kinetics, crystal growth, supersaturation control, solubility thermodynamics, heat/mass transfer) through robust, scalable processes that deliver clinical trial materials on time and on spec.
  • Innovate across a full toolkit of crystallization strategies — cooling, antisolvent, reactive, and seeded crystallization — paired with modern PAT tools (in-situ imaging, FBRM, ATR-FTIR, Raman) and QbD/DoE methodologies to build deep process understanding and real control.
  • Be the go-to crystallization expert on integrated drug substance project teams, driving particle engineering strategy (size distribution, morphology, polymorphic form, impurity rejection) and directly influencing regulatory filings (IND, IMPD, NDA) through your own authored content.
  • Bridge bench to plant to patient — partner with formulation, analytical, and manufacturing teams to ensure the APIs you develop translate into drug products that actually work, and lead scale-up and technology transfer to pilot plants and external CMOs.
  • Grow as a scientific leader — mentor emerging talent, publish and present in venues like AIChE and ACS, and help shape standards and control strategies across the broader organization.
  • Stay at the leading edge — engage with academic partners, pre-competitive consortia, and the latest advances in continuous crystallization and particle engineering.

Minimum Qualifications

  • PhD in Chemical Engineering
  • MSc in Chemical Engineering +7 years of experience
  • BSc in Chemical Engineering +10 years of experience

Additional Skills and Preferences

  • Hands-on experience designing, developing, and optimizing crystallization processes for pharmaceutical APIs — including polymorph screening, solid-form selection, and particle engineering.
  • Fluency with crystallization modeling and simulation tools (population balance modeling, thermodynamic solubility modeling), plus a data-driven approach to DoE and process analytics.
  • Work across both batch and continuous unit operations, with a solid grasp of the technical considerations behind equipment design, process monitoring, and PAT system integration.
  • A natural communicator — someone who can distill complex technical work into clear documentation and compelling presentations for audiences ranging from bench scientists to regulatory reviewers.
  • A track record of thriving in multidisciplinary teams, where influence comes from expertise and collaboration rather than title alone.
  • Leadership instincts: someone who leans into challenges, proactively clears roadblocks, and can lead through ambiguity even without formal authority.
  • A collaborative, team-first attitude paired with strong interpersonal skills.
  • Sharp problem-solving instincts, close attention to detail, and a results-driven approach.

Travel: 0 to 10%. Position Location: Indianapolis, IN LTC-N, onsite work 5 days/week.

Requirements

  • PhD in Chemical Engineering
  • MSc in Chemical Engineering +7 years of experience
  • BSc in Chemical Engineering +10 years of experience
  • Strong technical depth in crystallization science and engineering
  • Solid understanding of cGMP and ICH guidelines (Q6A, Q8, Q11)
  • Hands-on experience designing, developing, and optimizing crystallization processes for pharmaceutical APIs
  • Polymorph screening, solid-form selection, and particle engineering experience
  • Fluency with crystallization modeling and simulation tools (population balance modeling, thermodynamic solubility modeling)
  • Data-driven approach to DoE and process analytics
  • Experience with batch and continuous unit operations
  • Equipment design, process monitoring, and PAT system integration knowledge
  • Strong communication and presentation skills
  • Track record of thriving in multidisciplinary teams
  • Leadership instincts and ability to lead through ambiguity
  • Collaborative, team-first attitude with strong interpersonal skills
  • Sharp problem-solving instincts and attention to detail

Benefits

  • 401(k) Matching
  • Pension
  • Vacation Benefits
  • Medical Insurance
  • Dental Insurance
  • Vision Insurance
  • Prescription Drug Benefits
  • Flexible Spending Accounts
  • Life Insurance
  • Death Benefits
  • Employee Assistance Program
  • Fitness Benefits
  • Employee Clubs and Activities
  • Company Bonus

Company overview

Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.